ライフサイエンスコーパス: dermatologic

1 %), cardiac (11%), constitutional (11%), and dermatologic (11%).

2 strointestinal (34.0%), febrile (23.3%), and dermatologic (19.5%) diseases.

3 children with IBD had a higher prevalence of dermatologic (4.7% vs. 0.6%), hepatobiliary (including p

4 Toxicities were mainly constitutional (51%), dermatologic (82%), and GI (52%); there was one death on

5 syndromic form of JRRP associated with mild dermatologic abnormalities.

6 ilure, severe biventricular involvement, and dermatologic abnormalities.

7 7%), alterations in liver enzymes (64%), and dermatologic adverse effects (48%).

8 the most up-to-date information on managing dermatologic adverse effects of EGFRIs.

9 mptom-based treatment approach to the common dermatologic adverse effects seen with the epidermal gro

10 Assessment of type, severity, and impact of dermatologic adverse events (DAEs) necessitates well-dev

11 cts than traditional cytotoxic chemotherapy, dermatologic adverse events from EGFRIs are significantl

12 treatment discontinuations, hematologic and dermatologic adverse events, and growth inhibition.

13 the etiology of adult-onset respiratory and dermatologic allergic disorders remains unclear.

14 Eczema prevention is now an active area of dermatologic and allergy research.

15 Common treatment-related adverse events were dermatologic and gastrointestinal, predominantly grade 1

16 Diarrhea and dermatologic and hepatic toxicities were observed more f

17 uary 26, 2007, and February 17, 2012, at the Dermatologic and Mohs Micrographic Surgery Unit of the U

18 We investigated meetings of the Dermatologic and Ophthalmic Drug Advisory Committee (DOD

19 nt that has demonstrated activity in various dermatologic and rheumatologic conditions in addition to

20 ries, monkeypox manifested with a variety of dermatologic and systemic clinical findings.

21 ith the desire to scratch, is symptomatic of dermatologic and systemic disorders that often resist an

22 C from other disorders demonstrating similar dermatologic and systemic manifestations.

23 ce of rheumatologic, hematologic, pulmonary, dermatologic, and other findings in individuals with som

24 gic; cardiovascular; respiratory; digestive; dermatologic; and ear, nose, and throat as well as menta

25 er a 1-month period timed in accordance with dermatologic appointments.

26 ted at baseline, 1 month, and 6 months after dermatologic appointments.

27 of less than age 17 years using a systematic dermatologic approach.

28 Early detection of melanoma is a dermatologic area particularly poised to benefit from su

29 esults must be compared with caution because dermatologic assessment is more frequent in BRAF inhibit

30 At initial dermatologic assessment, 233 of 481 (48%) patients alrea

31 a cohort of patients who underwent the same dermatologic assessment.

32 ofile of cutaneous toxic effects, continuous dermatologic assessments should be provided for all pati

33 c study, we analyzed pre- and post-treatment dermatologic biopsies from 58 Fabry patients enrolled in

34 termining the optimal treatment course for a dermatologic burn wound requires knowledge of the wound'

35 remains a critical gap in understanding the dermatologic care and skin health of migrants in the US,

36 ed SAF teledermatology can improve access to dermatologic care in a public safety-net hospital settin

37 shifting be used to improve the delivery of dermatologic care in resource-poor settings worldwide?

38 design, and research on bundled payments for dermatologic care is limited.

39 Optimal posttransplant dermatologic care may be determined based on the race or

40 ere was a temporal increase in the amount of dermatologic care provided by APCs in Medicare.

41 Access to timely dermatologic care remains a challenge, especially for pa

42 rformed teledermoscopy may improve access to dermatologic care, but evidence to guide dermatoscope se

43 and areas with barriers to access to quality dermatologic care, findings from studies utilizing geosp

44 re organizations for delivering high-quality dermatologic care, improving access, and capturing other

45 ntial to expand the practice and delivery of dermatologic care.

46 may be used in the practice and delivery of dermatologic care.

47 t al. in this issue are essential to improve dermatologic care.

48 ating potential for improving the quality of dermatologic care.

49 ely be used as a method to provide pediatric dermatologic care.

50 s for improved access to and coordination of dermatologic care.

51 Most dermatologic cases are initially evaluated by nondermato

52 ocalized pruritus, in the absence of primary dermatologic causes.

53 ic population that can manifest as a serious dermatologic challenge for both patients and physicians.

54 A plethora of dermatologic changes have been described, some signaling

55 after adjustment for demographic, tumor, and dermatologic characteristics (yes vs no: log2 TMB [SE],

56 ir-associated eruption to better reflect the dermatologic classification of drug eruptions.

57 Participants included 2375 patients from a dermatologic clinic in Plantation, Florida.

58 iasis consecutively attending the outpatient dermatologic clinic of the University Hospital of Verona

59 OMs) that can be readily integrated into the dermatologic clinic setting, but the measurement propert

60 University hospital dermatologic clinic study involving the environmental co

61 ctions were invited to return for a complete dermatologic clinical assessment including skin biopsy,

62 Many dermatologic clinical trials have suffered from small sa

63 Conclusion and Relevance: Dermatologic clinical trials within the United States re

64 ne (3 mg per day) at the University of Miami dermatologic clinics from November 2022 to December 2023

65 use of JAK inhibitors for the management of dermatologic compared with nondermatologic conditions (4

66 Patients were those 18 years or older with dermatologic complaints who would have otherwise been re

67 reatment (including but not limited to pain, dermatologic complications, bleeding, and infection).

68 , neurologic illnesses, ocular symptoms, and dermatologic complications.

69 In this paper, the dermatologic computable phenotype literature is reviewed

70 Patients with dermatologic concerns were more likely to exhibit clinic

71 ern countries, particularly in patients with dermatologic concerns, where alterations in appearance m

72 kin lesions that do not conform to any known dermatologic condition and that are consciously or subco

73 ggest a potential link between the patient's dermatologic condition and this complication.

74 nitive diagnosis of CLE or any other non-CLE dermatologic condition as established by a board-certifi

75 Chronic spontaneous urticaria (CSU) is a dermatologic condition characterized by spontaneous, pru

76 ing prescribing practices for acne, a common dermatologic condition for which free samples are often

77 between this complication and the patient's dermatologic condition is suggested.

78 who consecutively consulted in the ED for a dermatologic condition was conducted under routine condi

79 be considered when photographing a patient's dermatologic condition.

80 he most common travel-related illnesses were dermatologic conditions (40%), diarrheal syndromes (25%)

81 se (primarily Campylobacter and Salmonella), dermatologic conditions (animal bites), systemic febrile

82 d 0.1%; odds ratio, 40.6 [CI, 10.2 to 161]); dermatologic conditions (deployed, 34.6%; nondeployed, 2

83 se reports, and case series that reported on dermatologic conditions affecting migrant populations wi

84 lper type 17, and regulatory T cells), to 21 dermatologic conditions associated with single nucleotid

85 ser surgery are indicated for certain common dermatologic conditions in children, although the optima

86 photography portraying individuals of color, dermatologic conditions in skin of color, and pigmentary

87 Although research on quality of life and dermatologic conditions is well represented in the liter

88 nvironmental exposures were risk factors for dermatologic conditions that developed at destination; (

89 ) refers to a group of erythematous, scaling dermatologic conditions that have been associated with s

90 e and during migration were risk factors for dermatologic conditions that presented at destination; (

91 Patients with dermatologic conditions were evaluated per the Internati

92 capsulated drug therapy for the treatment of dermatologic conditions with infectious and inflammatory

93 fibromyalgia, the chronic fatigue syndrome, dermatologic conditions, dyspepsia, physical health-rela

94 s, malignancies, inflammatory bowel disease, dermatologic conditions, or solid-organ or bone marrow t

95 diagnose AD and differentiate it from other dermatologic conditions, reducing reliance on subjective

96 race-matched patients presenting with benign dermatologic conditions.

97 decrease the prevalence of diaper-associated dermatologic conditions.

98 d therapeutic strategies across a variety of dermatologic conditions.

99 the same association may not be observed in dermatologic conditions.

100 tors are increasingly used across a range of dermatologic conditions.

101 ndomized controlled trials across a range of dermatologic conditions.

102 systemic drugs for the treatment of various dermatologic conditions.

103 Articles discussed a range of dermatologic conditions: infections (45 [51.7%]), inflam

104 ations introduced SDM tools specifically for dermatologic conditions; of these, only 2 tools were val

105 eaching modernized medical school curricula, dermatologic conferences, and the American Board of Derm

106 nue triple therapy with close monitoring and dermatologic consultation.

107 Many hospitals do not have inpatient dermatologic consultative services, and most have reduce

108 Identifying dermatologic contraindications to smallpox vaccination b

109 2018 and September 2019 from 11 major German Dermatologic Cooperative Oncology Group skin cancer cent

110 The final results of the German Dermatologic Cooperative Oncology Group trial with a med

111 ces Physician Fee Schedule for commonly used dermatologic Current Procedural Terminology (CPT) codes

112 entations of racial and ethnic minorities in dermatologic curricula are being addressed through impro

113 iverse and inclusive image representation in dermatologic curricula is vital to counteracting implici

114 r encounter were greater than in the general dermatologic data set.

115 Dichotomous dermatologic depictions of heroes and villains in movies

116 The most common specific dermatologic diagnoses were cutaneous larva migrans, myi

117 For inclusion, articles needed to include a dermatologic diagnosis as well as discussion of SDM or p

118 Photographs are invaluable dermatologic diagnostic, management, research, teaching,

119 equently reported symptoms included cardiac, dermatologic, digestive, and ear, nose, and throat disor

120 At dermatologic digital follow-up aided by confocal microsc

121 etected among 2 MITF p.E318K carriers during dermatologic digital follow-up.

122 By identifying areas with high rates of dermatologic disease and areas with barriers to access t

123 een research and clinical care: knowledge of dermatologic disease has facilitated the understanding o

124 Lichen planus is a dermatologic disease that affects both skin and mucosa.

125 Acne is a dermatologic disease with a strong pathologic associatio

126 Dermatologic disease, although seldom life threatening,

127 vidends in identifying the genetic causes of dermatologic disease, both in heritable mutations and th

128 ward genetics in mice can be used to explore dermatologic disease.

129 Four patients (7.9%) had an associated dermatologic disease.

130 n be performed to explore various aspects of dermatologic disease.

131 Multivariable analysis showed that allergic dermatologic diseases (P < 0.001; OR: 4.5; 95% CI: 2.4-8

132 The vast majority of polymorphisms for human dermatologic diseases fall in noncoding DNA regions, lea

133 Most susceptibility loci for complex dermatologic diseases fall within non-coding regions, ma

134 Dermatologic diseases often exhibit distinct geographic

135 of rheumatic, hepatobiliary, pancreatic, and dermatologic diseases were compared with age-/sex-/count

136 atched controls without chronic inflammatory dermatologic diseases were recruited from the same depar

137 sity is a major risk factor for inflammatory dermatologic diseases, including atopic dermatitis and p

138 stem as well as current zebrafish models for dermatologic diseases, including melanoma, squamous cell

139 the genomic regulatory mechanisms underlying dermatologic diseases.

140 ses, blood and solid organ malignancies, and dermatologic diseases.

141 help inform the treatment and management of dermatologic diseases.

142 While typically considered a dermatologic disorder, intraoral signs of neurofibromato

143 A wide range of autoimmune/dermatologic disorders can manifest as DG, although the

144 rch in healthy individuals and patients with dermatologic disorders has provided insights into the co

145 rome (SJS) are rare, acute, life-threatening dermatologic disorders involving the skin and mucous mem

146 Psychosocial dysfunction in dermatologic disorders is more frequent than commonly re

147 critical role in the pathogeneses of several dermatologic disorders, including infections, malignanci

148 ngiogenesis and its potential for therapy of dermatologic disorders, one must understand the many dua

149 eutic targets to explore in the treatment of dermatologic disorders.

150 the progression of pathology and prevent the dermatologic disturbances in Fabry patients, and that pe

151 cal signs of Fabry disease often manifest as dermatologic disturbances such as angiokeratomata, hypoh

152 requesting price data on commonly prescribed dermatologic drugs in 2009, 2011, 2014, and 2015.

153 The price of prescription dermatologic drugs rose considerably from 2009 to 2015,

154 ade 3 and 4 toxicities were neutropenia, GI, dermatologic effects, pain, and electrolyte disturbances

155 y the primary oncology team and referred for dermatologic evaluation as appropriate.

156 Dermatologic evaluation for nail abnormalities was perfo

157 , neutropenia (42%), neurologic events (7%), dermatologic events (7%), and thromboembolism (2%).

158 ad higher rates of cardiac, respiratory, and dermatologic events than did the placebo group.

159 with ADA-SCID were evaluated with a complete dermatologic examination and skin biopsy when indicated.

160 A systematic dermatologic examination of 16 patients included in a Eu

161 Patients underwent a thorough general and dermatologic examination, including skin biopsies, vascu

162 On dermatologic examination, subacute cutaneous lupus eryth

163 mline mutations when found to have MBAITs on dermatologic examination.

164 hite than white OTRs reported having regular dermatologic examinations (5 [11.4%] vs 8 [36.4%]) and k

165 amily have undergone complete neurologic and dermatologic examinations.

166 s different types of HSR and highlights some dermatologic examples that have resulted in improved hea

167 ions was also suggested, while arthritis and dermatologic features appeared to be most influenced by

168 Dermatologic features provide a major diagnostic clue to

169 able adult progeroid syndrome with prominent dermatologic features, constitutional genomic instabilit

170 In this cross-sectional study, dermatologic findings for film heroes and villains in ma

171 The dermatologic findings of 16 cases of CS and COFS syndrom

172 in skin dichotomy in film by (1) identifying dermatologic findings of the all-time top 10 American fi

173 Dermatologic findings of the all-time top 10 American vi

174 es include identification and frequencies of dermatologic findings of the top 10 film villains and of

175 lains have a higher incidence of significant dermatologic findings than the top 10 heroes (60% vs 0%;

176 American film villains, (2) comparing these dermatologic findings to the all-time top 10 American fi

177 all-time top 10 American film villains have dermatologic findings, including cosmetically significan

178 acilitated by an awareness of the associated dermatologic findings.

179 Our findings indicate the relevance of dermatologic follow-up in HSCT recipients.

180 g of policy and intervention to help improve dermatologic healthcare outcomes and promote health equi

181 A dermatologic history of KHF may be a risk factor for PVR

182 ry, tumor characteristics, demographics, and dermatologic history were collected via retrospective me

183 Guggulipid also appeared to cause a dermatologic hypersensitivity reaction in some patients.

184 rs only) were high across a wide spectrum of dermatologic illnesses and did not vary significantly by

185 e are no DICOM standards for camera-acquired dermatologic images to date.

186 Dermatologic imaging is evolving without defined standar

187 A variety of dermatologic immune-related adverse events including mac

188 ypes 1 and 2 cause infections manifesting as dermatologic, immunologic, and neurologic disorders.

189 e CRPS as a neurological disorder with major dermatologic implications.

190 the safety risks of JAK inhibitors used for dermatologic indications.

191 Of the individual organ systems, dermatologic involvement had the largest effect (P = 0.0

192 lyses revealed that malar rash, a subtype of dermatologic involvement, was linked significantly (P =

193 In conclusion, patients with dermatologic issues and those seeking cosmetic procedure

194 sis, often aided by recognition of a keynote dermatologic lesion, may permit prompt, timely treatment

195 es to reduce the iron overload and clear the dermatologic lesions in porphyria cutanea tarda, and dia

196 Dermatologic lesions included oral ulcers (100%), genita

197 cular neoplasm that frequently presents with dermatologic lesions.

198 An extensive search of the dental and dermatologic literature was performed on MEDLINE.

199 ented to the emergency department with acute dermatologic lower extremity symptoms from October 11, 2

200 LCV is a rare dermatologic manifestation of Crohn's disease (CD) and m

201 Cultural practices that present with dermatologic manifestations in the pediatric population

202 are form of vasculitis and one of the rarest dermatologic manifestations of CD, appearing at any stag

203 matomyositis and tacrolimus ointment for the dermatologic manifestations of juvenile dermatomyositis

204 Furthermore, it gathers all the dermatologic manifestations reported during the disease

205 uced, and has classic systemic, mucosal, and dermatologic manifestations.

206 sleep deprivation, and exercise, on several dermatologic measures: transepidermal water loss, recove

207 tors associated with primary nonadherence to dermatologic medications and study whether electronic pr

208 3, among a cohort of new patients prescribed dermatologic medications at a single, urban, safety-net

209 pecialties as well as primary care prescribe dermatologic medications; as insurance formularies becom

210 ission; this hyperinflammatory syndrome with dermatologic, mucocutaneous, and gastrointestinal manife

211 Grade 3 and higher toxicities, primarily dermatologic, occurred in 63% during neoadjuvant treatme

212 nical trial was conducted in ambulatory care dermatologic offices from June 6, 2011, to April 14, 201

213 Tacrolimus dermatologic ointment is a potentially safe and effectiv

214 ies as well as treatments approved for other dermatologic or oncologic conditions.

215 ry and a potentially increased risk of local dermatologic or oncologic diseases over a longer period.

216 nts were women who had taken minocycline for dermatologic or rheumatologic disorders for extended per

217 career paths of the founders of the major US dermatologic organizations, such as the New York Dermato

218 ingly providing care for children undergoing dermatologic out-of-operating room procedures.

219 cyte antigen loci with carbamazepine-induced dermatologic outcome and MC4R with atypical antipsychoti

220 ted incidence of PCP in all immunosuppressed dermatologic patients (0.1% vs 1.3%; chi21 = 8.2; P = .0

221 region, and, as mice lacking IRF-2 exhibit a dermatologic phenotype resembling many aspects of human

222 atively and qualitatively, and (3) analyzing dermatologic portrayals of film villains in depth.

223 In the general dermatologic practice excluding Mohs surgeons, destructi

224 ry and laser therapy applicable to pediatric dermatologic practice have been made.

225 h 31, 2020, at the Emory Clinic, an academic dermatologic practice in Atlanta, Georgia.

226 ceived lack of evidence to justify change in dermatologic practice, difficulty navigating patient dem

227 In the general dermatologic practice, the mean (SD) wRVUs per encounter

228 of those receiving betamethasone-containing dermatologic preparations had documented hypopituitary-a

229 lfa-2b, and various betamethasone-containing dermatologic preparations.

230 The effects of early diagnosis, dermatologic presentation, and antifungal treatment on o

231 those returning from south central Asia, and dermatologic problems among those returning from the Car

232 t, as the number of outpatient surgeries for dermatologic problems in infants and children is steadil

233 , dermatologist utilization of Medicare, and dermatologic procedural volume have all increased over t

234 m 2007 to 2021, there was a mean decrease in dermatologic procedure reimbursement of -4.8% after adju

235 n noninvasive to minimally invasive cosmetic dermatologic procedures are widely believed to be safe g

236 ine and prilocaine) is invaluable for office dermatologic procedures in children.

237 PURPOSE OF REVIEW: Pediatric dermatologic procedures performed outside of the operati

238 ywood Dermatology), 2 patients presented for dermatologic procedures, complicated by persistent bleed

239 Noninvasive to minimally invasive cosmetic dermatologic procedures, including energy, neurotoxin, a

240 nses, even though patients who develop early dermatologic reactions have shown to have a positive out

241 in 21% of patients (severe in 3%) and severe dermatologic reactions in 8%.

242 association of complete response with early dermatologic reactions supports the role of a specific i

243 seline characteristics, development of early dermatologic reactions, and cause of treatment discontin

244 All but one patient developed early dermatologic reactions, and seven patients discontinued

245 Dermatologic remote expertise invalidated, enlarged, or

246 ed 101 SLE-affected sibpairs with respect to dermatologic, renal, immunologic, hematologic, neurologi

247 ighlight the potential utility of IMC within dermatologic research and clinical applications.

248 Adjusted NIH funding for dermatologic research diminished by 4.6% from $67.3 mill

249 lthough there have been increased efforts in dermatologic research to improve representation of patie

250 The JID is a major resource for publishing dermatologic research.

251 mics data; and discuss their applications in dermatologic research.

252 r 2016 for all patients receiving a TNFi for dermatologic, rheumatologic, or gastroenterologic diagno

253 its editorial leadership and the quality of dermatologic science have grown apace.

254 of recipients who may benefit from intensive dermatologic screening and immunosuppression reduction.

255 n in educational materials, expand access to dermatologic services by improving on the provision of t

256 the application of network geometry in other dermatologic settings as well as in science and technolo

257 so does the need to recognize and treat the dermatologic side-effects of these agents.

258 ldren that include a prominent or diagnostic dermatologic sign/symptom.

259 However, those who have gastrointestinal or dermatologic signs and symptoms and many cysts in stool

260 Some dermatologic signs may also represent the hallmark lesio

261 tical need exists for developing a validated dermatologic-specific treatment satisfaction instrument.

262 to implement better practices, especially in dermatologic subspecialties.

263 d, suggesting responsiveness of patients and dermatologic surgeons to public health concerns regardin

264 g immediately with TPFM on site at Rochester Dermatologic Surgery (Victor, New York) between October

265 zumab, an anti-PD-1 antibody, at an academic dermatologic surgery section and cancer center.

266 rs useful and reliable for the evaluation of dermatologic surgery skills.

267 tissue from Mohs surgical excisions from the dermatologic surgery units at Memorial Sloan Kettering C

268 medical dermatology, pediatric dermatology, dermatologic surgery, dermatopathology, or education and

269 ical skills (OSATS) to measure competence in dermatologic surgery.

270 Opioids were over prescribed after dermatologic surgery.

271 bleeding is the most common complication of dermatologic surgery.

272 s been reported for the use of hemostasis in dermatologic surgery.

273 e for facial pseudoaneurysms that complicate dermatologic surgery.

274 events of BRAF inhibitors; therefore, strict dermatologic surveillance in a referral center aided by

275 ish standardized guidelines on follow-up and dermatologic surveillance in this high-risk patient popu

276 Strict dermatologic surveillance, periodic self-examination, an

277 alized patient counseling and posttransplant dermatologic surveillance.

278 Persistent pruritus is a common disabling dermatologic symptom associated with different etiologic

279 etal symptoms (OR, 2.55; 95% CI, 1.32-4.94), dermatologic symptoms (OR, 2.18; 95% CI, 10.7-4.45), or

280 luded a spectrum of demographic, ophthalmic, dermatologic, systemic, socioeconomic, or occupational f

281 ratory failure, asthma), musculoskeletal and dermatologic systems that are deeply interconnected with

282 me color reversal film was a cornerstone for dermatologic teaching innovations that transformed 20th

283 infections (16.3% vs. 0.8%); neutropenia and dermatologic toxic effects were more frequent with lenal

284 These dermatologic toxicities have previously led to reduction

285 ource in approaching patients on EGFRIs with dermatologic toxicities.

286 ression, constitutional symptoms, and GI and dermatologic toxicities.

287 icant edema, hypersensitivity reactions, and dermatologic toxicities.

288 tom (4%), hand and foot reaction (2%), other dermatologic toxicity (6%), other GI toxicity (4%), infe

289 Each dermatologic toxicity is described; prophylaxis and trea

290 evel, seven (30%) of 23 patients had grade 3 dermatologic toxicity.

291 rade 3+ toxicity included 15.1% GI and 37.7% dermatologic toxicity; all acute grade 4 toxicities were

292 me-style of didactic that remains central to dermatologic training programs today.

293 of flare episodes (24% [122 of 513]) had no dermatologic treatment 30 days before, during, or 30 day

294 ocular treatment, and FDO patients received dermatologic treatment.

295 nalyze the geometry of the evidence base for dermatologic treatments.

296 ling and licensure bodies and to demonstrate dermatologic value.

297 Compared with general dermatologic visits with White patients, visits with Bla

298 is 18%, pulmonary arterial hypertension 9%), dermatologic (warts 53%, panniculitis 30%), neoplastic (

299 s of granulomatous inflammation, followed by dermatologic work-up and systemic investigations.

300 Extensive dermatologic workup and serial skin biopsies failed to r